The yellow fever vaccine: A history

Yale Journal of Biology and Medicine

Volumn 83, Issue 2, 2010, Pages 77-85

  Frierson, J Gordon ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell culture; History; Theiler; Vaccine; Yellow fever

Indexed keywords

YELLOW FEVER VACCINE;

AFRICA; ARTICLE; ENCEPHALITIS; ERADICATION THERAPY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; JAUNDICE; NONHUMAN; VACCINE FAILURE; VACCINE PRODUCTION; VIRUS CELL INTERACTION; VIRUS ISOLATION; YELLOW FEVER; ANIMAL; HAPLORHINI; HISTORY; MOUSE;

MUS;

ANIMALS; HAPLORHINI; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MICE; YELLOW FEVER VACCINE;

EID: 77957325791     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Sternberg GM. Report of the Etiology and Prevention of Yellow Fever. Washington: Government Printing Office; 1890. p. 49-65.
2. Manson P. Tropical Diseases. A Manual of the Diseases ofWarm Climates. 1st ed. London: Cassell & Co.; 1898. p. 127.
3. Reed W, et al. The etiology of yellow fever. An additional note. J Amer Med Assoc. 1901;36:431-40.
4. Yellow fever. A compilation of various publications. Results of the work of Maj.Walter Reed, Medical Corps, United States Army, and theYellow Fever Commission. 61st Congress, 3rd session. Senate Doc No 822.Washington: Government Printing Office; 1911.
5. Guiteras J. Experimental yellow fever at the inoculation station of the Sanitary Department of Havana with a view to producing immunization. AmericanMedicine. 1901;3:809-17.
6. Noguchi H. Etiology of yellow fever: II. Transmission experiments on yellow fever. J Exp Med. 1919;29:565-84.
7. Noguchi H. Etiology of yellow fever: V. Properties of blood serum of yellow fever patients in relation to Leptospira icteroides. J Exp Med. 1919;30:9-12.
8. Noguchi H. Etiology of yellow fever: IX. Mosquitoes in relation to yellow fever. J Exp Med. 1920;30:401-10.
9. Noguchi H. Etiology of yellow fever: X. Comparative immunologic studies on Leptospira icteroides and Leptospira icterohemorrhagiae. J Exp Med. 1920;31:135-58.
10. Sorel F. La vaccination anti-amarile en Afrique Occidentale Francaise mise en application du procédé de vaccination Sellards-Laigret. Bull Off Internat d'Hyg Publique. 1936;28:1325-56.
11. Atwo dose vaccine given at the Broad Street Hospital, NYC. New York Times. 1920 Dec 10.
12. Noguchi H, Pareja W. Prophylactic Inoculation against Yellow Fever. J Amer Med Assoc. 1921;76:96-9.
13. Noguchi H. Prophylaxis and Serum Therapy of Yellow Fever. J Amer Med Assoc. 1921;77:181-5.
14. Lebredo MG. Considerations suggested by publications of Dr. Noguchi on experimental yellow fever - with appendix. Trans Amer Soc Trop Med. 1919;19:499-512.
15. AgramonteA. Some observations upon yellow fever prophylaxis. Proc InternatConf onHealth Problems in Tropical America. Kingston, Jamaica; 1924. p. 201-227. Reprinted in J Trop Med and Hyg. 1924;27:285-7.
16. TheilerM, SellardsAW. The relationship of L icterohemorrhagicae and L. icteroides. Amer J Trop Med. 1926;6:383-402.
17. Hudson NP. Adrian Stokes and yellow fever research. Trans Roy Soc Trop Med Hyg. 1966;60:170-4.
18. Plesset IR. Noguchi and his Patrons. London: Fairleigh Dickinson University Press; 1980.
19. Williams G. The Plague Killers. New York: Charles Scribner's Sons; 1969. p. 226-49.
20. Dolman CE. Hideyo Noguchi (1876-1928): His final effort. Clio Medica. 1977;12:131-45.
21. Stokes A, et al. The transmission of yellow fever to Macacus rhesus, Preliminary note. J Amer Med Assoc. 1928;90:253-5.
22. Theiler M, Sellards AW. The immunological relationship of yellow fever as it occurs in WestAfrica and in SouthAmerica.Ann Trop Med Parasitol. 1928;22:449-60.
23. Vargues R. Hommage a Jean Laigret: La petite histoire de la découverte de la vaccination contre la fièvre jaune. Presse Medicale. 1966;74:2441-2.
24. Sellards W, Mathis C, Laigret J. Sensibilité du Macacus rhesus au virus de la fièvre jaune. CR Acad Sci. 1928;186:604-6.
25. Ducloux M. Francois Miyeli (1911 - 1927 - 1973) et la souche francaise amarile. Bull Soc Med Afr Noire Lang Franc. 1975;20:174-9.
26. Sellards AW, Hindle E. The Preservation of yellow fever virus. Brit Med J. 1928;1:713-14.
27. Hindle E. An experimental study of yellow fever. Trans Roy Soc Trop Med. 1929;22:405-34.
28. Andervont HB. Activity of herpetic virus in mice. J Infect Dis. 1929;44:383-93.
29. Theiler M. Studies on the action of yellow fever virus on mice. Ann Trop Med Parasit. 1930;24:249-72.
30. Williams G. The Plague Killers. New York: Charles Scribner's Sons; 1969. p. 260-1.
31. Berry GP, Kitchen SF.Yellow Fever accidentally contracted in the laboratory. Amer J Trop Med. 1931;11:365-434.
32. Theiler M, Smith HH. Use of yellow fever virusmodified by in vivo cultivation for human immunization. J ExperMed. 1937;65:787-800.
33. Strode GK, editor. Yellow Fever. New York: McGraw-Hill Book Co.; 1951. Chapter 2.
34. Sawyer WA, et al. Vaccination of humans against yellow fever with immune serum and virus fixed for mice. Proc Soc Exper Biol Med. 1931;29:62-4.
35. Theiler M. Neutralization tests with immune yellow fever sera and a strain of yellow fever virus adapted to mice.Ann TropMed Parasit. 1931;25:69-77.
36. Laigret J. La vaccination contre la fievre jaune. Arch Inst Pasteur Paris. 1934;23:413-37.
37. Sorel F. La vaccination anti-amarile en Afrique Occidentale Francaise mise en application du procédé de vaccination Sellards-Laigret. Bull Off Internat d'Hyg Publique. 1936;28:1325-56.
38. Laigret J.Au sujet des reactions nerveuses de la vaccination contre la fievre jaune. Bull Soc Pathol Exot. 1936;29:823-8.
39. Nicolle C, Laigret J. Vaccination contre la fievre jaune a l'aide d'une seule inoculation du virus amaril vivant, desséché et enrobé. Arch Inst Pasteur Tunis. 1936;25:28-39.
40. Peltier M, et al. Vaccination mixte contre la fievre jaune et la variole sur des populations indigenes du Senegal.Ann Inst Past (Dakar). 1940;65;146-69.
41. Peltier M. Yellow fever vaccination, simple or associated with vaccination against smallpox, of the populations of FrenchWestAfrica by the method of the Pasteur Institute of Dakar. Amer J Pub Hlth. 1947;37:1026-32.
42. Durieux C.Mass yellow fever vaccination in FrenchAfrica south of the Sahara. In: Smithburn K, et al., editors.Yellow Fever Vaccination. Geneva: World Health Organization; 1956. p. 115-21.
43. Durieux C. Preparation of yellowfever vaccine at the Institute Pasteur, Dakar. In: Smithburn K, et al., editors. Yellow Fever Vaccination. Geneva: World Health Organization; 1956. p. 31-43.
44. Stuart G. Reactions following vaccination against yellow fever. In: Smithburn, K, et al., editors. Yellow Fever Vaccination. Geneva: World Health Organization; 1956. p. 143-189.
45. Theiler M, Smith HH. The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus. J Exper Med. 1937;65:767-86.
46. Theiler M, Smith HH. The use of yellow fever virus modified by in vitro cultivation for human immunzation. J Exp Med. 1937;65:787-800.
47. Smith HH, et al. Yellow fever vaccination with cultured virus (17D) without immune serum.Amer J Trop Med Hyg. 1938;18:437-68.
48. Smith HH. Life's a Pleasant Institution: The Peregrinations of a Rockefeller Doctor. Tucson: Smith; 1978.
49. Fox JP, et al. Encephalitis in man following vaccination with 17D yellow fever virus. Amer J Hyg. 1942;36:117-42.
50. Soper FL, Smith HH. Yellow fever vaccination with cultivated virus and immune and hyperimmune serum. Amer J Trop Med. 1938;18:111-34.
51. Findlay GM, MacCallum FO. Note on acute hepatitis and yellowfever immunizaation. Tran Roy Soc TropMed Hyg. 1937;31:297-308.
52. Fox JP, et al. Observations on the occurrence of icterus in Brazil following vaccination against yellow fever. Amer J Hyg. 1942;36:68-116.
53. Sawyer WA, et al. Jaundice in Army Personnel in theWestern Region of the United States and its Relation toVaccination againstYellow Fever (part I).Amer J Hyg. 1944;39:337-430.
54. Farley J. To Cast Out Disease: A history of the International Health Division of the Rockefeller Foundation. New York: Oxford University Press; 2004. p. 178.
55. Time Magazine. 1942 Aug 3:57-8
56. Editorials. Chicago Tribune. 1942 July 27 and 30.
57. Sawyer WA, et al. Jaundice in army personnel in the western region of the United States and its relation to vaccination against yellow fever (parts II, III, and IV). Amer J Hyg. 1944;40:35-107.
58. Norman JE, et al. Mortality follow-up of the 1942 epidemic of hepatitis B in the USArmy. Hepatology. 1993;18:790-7.
59. Dakar yellow fever vaccine: An experiment to determine the immunizing power of yellow fever vaccine produced by the Pasteur Institute at Dakar. Epidem Inform Bull. 1946;2:618-32.
60. MacNamara FN. Reactions following neurotropic yellow fever vaccine given by scarification in Nigeria. Trans Roy Soc TropMed Hyg. 1953;47:199-208.
61. de Marsaguet GC, Thomas J. Les etats encephalo-meninges succedant aux vaccinations antivariolique et antiamarile associees ou isolees.Med Tropicale. 1961;21:115-128.
62. Stefanopoulo GJ, Duvolon S. Réactions observées au cours de la vaccination contre la fievre jaune atténué de culture (souche 17D). Bull et Mem de la Soc Med des Hop (Paris). 1947;30-31:989-99.
63. Draper CC, Knott EG. Failure to respond to vaccination with 17D yellow fever virus by scarification, and its significance.WestAfric Med J. 1964;13:78-82.
64. Dick GWA. A preliminary evaluation of the immunizing power of chick-embryo 17D yellow fever vaccine inoculated by scarification. Amer J Hyg. 1952;55:140-53.
65. Monath TP. Yellow fever vaccines: the success of empiricism, pitfalls of application, and transition to molecular vaccinology. In: Plotkin SA, Fantini B, editors. Vaccinia, Vaccination, and Vaccinology. Paris: Elsevier; 1996. p. 157-82.
66. Harris RJC, et al. Contaminant viruses in two live virus vaccines produced in chick cells. J Hygiene. 1966;64:1-7.
67. Piraino F, et al. Serologic survey of man for avian leukosis virus infection. J Immunol. 1967;98:702-6.
68. Draper CC.Ayellow fever vaccine free from avian leucosis viruses. J Hyg Camb. 1967;65:505-513.
69. Tauroso NM, et al. Yellow fever vaccine I. Development of a vaccine seed free from contaminating avian leucosis viruses. Proc Soc Exp Biol Med. 1968;127:1116-20.
70. Anderson PS, et al. Yellow Fever Vaccination, avian leukosis virus, and cancer risk in man. Science. 1972;177:76-7.
71. Monath TP. Stability of yellow fever vaccine. Dev Biol Stand. 1996;87:219-25.
72. Rice CM, et al. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science. 1985;229:726-33.
73. Monath TP. Glad tidings from yellow fever research. Science. 1985;229:734-5.
74. Edelman R. Dengue vaccines approach the finish line. Clin Inf Dis. 2007:45(Suppl 1):S56-60.
75. Norrby E.Yellow fever andMax Theiler: the only Nobel Prize for a virus vaccine. J Exp Med. 2007; 204:2779-84.
76. Yellow fever in Africa and South America, 2006.Weekly Epidemiol Record. 2008;83:69-76.